Introduction {#sec1_1}
============

Glaucoma is the leading cause of irreversible blindness in the world \[[@B1]\]. Glaucoma treatment is aimed at lowering intraocular pressure (IOP) in an effort to prevent further damage to the optic nerve and slow down progression of visual field loss damage. IOP can be lowered with medications, laser procedures, or incisional surgeries. Glaucoma drainage devices (GDD), such as the Ahmed valve and Baerveldt implant are often utilized after more conservative treatments have failed \[[@B2]\].

Known complications of GDD surgery include intraocular bleeding, choroidal detachment, erosion of the conjunctiva, hypotony, corneal decompensation, strabismus, tube obstruction, tube exposure, and infection \[[@B3], [@B4]\].

Risk factors for tube exposure include smoking, pseudoexfoliation glaucoma, history of dry eye syndrome, diabetes, younger age, and inflammation \[[@B5], [@B6]\]. Sclera, pericardium, cornea, and dura mater are the commonly used graft materials to cover a GDD \[[@B7]\]. The most significant complication related to exposure is endophthalmitis, with a reported range from 0.8 to 6.3% and a mean of 2% \[[@B8]\]. Our literature search in June 2017 via PubMed revealed no research that detailed frequencies or common causes of external infections of the conjunctiva and patch graft following GDD surgery.

Case Description {#sec1_2}
================

Our patient is a 69-year-old female with a history of severe-stage primary open-angle glaucoma refractory to previous trabeculectomy and on maximum topical medical treatment in the left eye. She underwent placement of a Baerveldt glaucoma implant with a scleral patch graft (SPG) in the left eye with vicryl suture tube ligature. The surgery was unremarkable and without complications. On postoperative day 1, she was doing well, the tube was in good position, and her incision was closed with no exposure. Her IOP was 34 mm Hg, and her best corrected visual acuity (BCVA) was 20/70 in the left eye. She was treated with our routine postoperative regimen of moxifloxacin 4 times a day for 1 week and prednisolone acetate starting at 4 times a day and tapered weekly. She was also placed on her preoperative glaucoma drops, while awaiting ligature dissolution. At postoperative week 3, the patient reported irritation and discharge in the left eye and was noted to have an abscess and erosion of underlying conjunctiva and partial erosion of the SPG. Her vision was slightly improved with a BCVA of 20/60 and an IOP of 14 mm Hg at this time. A mucoid, pigmented plaque from the abscess was sent for culture. The patient was restarted on moxifloxacin 4 times a day.

Culture results were finalized as coagulase-negative *Staphylococcus*, susceptible to gentamicin. She was started on gentamicin, and moxifloxacin was continued. At the follow-up visit, slit-lamp examination revealed an enlarging area of thinning and erosion of the SPG with overlying avascular conjunctiva with a central area of eroded conjunctiva. There was no infiltrate and no signs of active infection. The wound was Seidel negative with no exposure of the tube.

It was at this visit that the patient reported developing a rash involving her back, right arm, and abdomen with scattered abscesses. She went to a walk-in clinic 1 week prior and was initially started on topical steroids for the skin infection while waiting for culture results which later grew *Staphylococcus aureus*. Topical steroid was reportedly stopped and cephalexin was started by the urgent care physician.

At her subsequent follow-up a week later, the erosion of the conjunctiva and SPG had progressed with exposure of the glaucoma implant (Fig. [1](#F1){ref-type="fig"}). The patient was scheduled for wound revision with removal of the SPG, conjunctivoplasty, and placement of a new SPG (Fig. [2](#F2){ref-type="fig"}). The old SPG and surrounding conjunctiva were sent for culture and showed no growth of bacteria or fungus.

At postoperative week 6 after the revision, the tube remained covered with no recurrence of erosion or infection, and her skin lesions resolved on the regimen of cephalexin.

Discussion {#sec1_3}
==========

Infection occurs in roughly 1% of GDD procedures and can occur months to years after the initial operation, sometimes requiring shunt removal; of those infections, most cases are forms of endophthalmitis \[[@B9]\]. In a retrospective study of Ahmed glaucoma valve implant complications in 542 eyes of 505 patients, endophthalmitis occurred in 1.7% of patients, with the most common organisms including *Streptococcus* species and *Haemophilus influenzae* \[[@B10]\].

Graft exposure is a major risk factor for infection \[[@B9]\]. In a recent retrospective case series of 763 cases comparing graft materials, exposure for SPGs was lowest (0.5%) compared to pericardium (7.9%) and cornea (9.2%), although it approached but did not reach statistical significance (*p* = 0.072) \[[@B9]\]. The following studies have different rates of tube exposure for the various graft materials, but a far smaller sample size. In one study of 64 eyes comparing sclera, dura, and pericardium patch grafts, exposure rates were 4.3, 5.6, and 0%, respectively \[[@B11]\]. Regarding pericardial grafts in another study, the exposure rate was 16% with single-thickness processed pericardium in 31 eyes compared to 0% in 59 eyes covered with double-thickness processed pericardium (*p* = 0.0002) \[[@B12]\]. A separate study looking at corneal patch grafts in 45 eyes noted a tube exposure frequency of 2.2% \[[@B13]\], while another looking at VisionGraft gamma-irradiated cornea had an exposure rate of 1.8% in 169 eyes \[[@B14]\]. The sample sizes of the latter studies were far smaller than that of the first study, which suggests a slight advantage for SPG in regards to tube exposure, but it is reasonable to believe that double-thickness processed pericardium and gamma-irradiated cornea may also reduce risk of exposure and possible subsequent infection.

Our literature search yielded many studies looking at endophthalmitis in the postoperative period, with a paucity of reports of focal, external infections of the conjunctiva or the patch graft, and no reported cases of that kind of infection due to coagulase-negative *Staphylococcus* leading to an abscess. In a cross-sectional study of ocular infections unrelated to GDD placement, *S. aureus* was the leading cause of conjunctivitis (21.5%) with coagulase-negative *Staphylococcus* as the second leading cause (16.5%) \[[@B15]\]. We found one case of an external infection in a patient after GDD surgery for neovascular glaucoma, which was due to methicillin-resistant *S. aureus* \[[@B16]\].

Our patient had a conjunctival pigmented mucoid plaque with underlying abscess formation and conjunctival melt following an uneventful GDD placement. Typically, erosions lead to underlying infections, but in this case, it was the reverse. Our patient\'s SPG infection was due to coagulase-negative *Staphylococcus* infection most likely due to a foreign body which caused colonization and involvement of the ocular surface. That strain is common in nosocomial infections and frequently related to foreign bodies. Another possibility is that the SPG itself may have carried infection preoperatively. Given that the two strains were different, it is unlikely that it was a systemic infection that manifested in the eye. Her concurrent wound infection and skin infection, however, are curious and may have been due to some predisposing systemic vulnerability.

There are 2 disease entities that lead to recurrent *Staphylococcus* abscesses: chronic granulomatous disease and hyper IgE syndrome (i.e., Job syndrome). However, these usually present early in life and have other presenting features such as short stature, chronic diarrhea, and gingivitis for chronic granulomatous disease and coarse facies, retained primary teeth, and eczema for hyper IgE syndrome, none of which were present in our patient. Given the very low likelihood of these conditions, we did not pursue further testing.

Clinicians must be aware of conditions that could lead to poor postoperative outcomes such as concurrent staphylococcal skin infection, as in our patient. At-risk patients may benefit from alternative nonincisional therapies such as transscleral diode cyclophotocoagulation, which does not have an associated infection risk and has shown to have similar outcomes at 2 years when compared to Ahmed glaucoma valve in patients with neovascular glaucoma \[[@B17]\]. Known *Staphylococcus* carriers or those predisposed to infection by *Staphylococcus* species may benefit from preoperative mupirocin treatment, chlorhexidine baths, the use of antibiotics known to have a high sensitivity to respective strains, and avoidance of those antibiotics with high resistance, such as fluoroquinolones \[[@B18]\]. Patients with higher risk of infection would also benefit from SPGs, gamma-irradiated cornea, or double-thickness pericardium \[[@B11], [@B12], [@B14]\]. Surgical and nonsurgical options, graft material, and perioperative treatment should be based on patient characteristics, underlying predisposing conditions, and known bacterial colonization.
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![The erosion is radial, which suggests that it is unrelated to the circumferential incision.](cop-0008-0521-g01){#F1}

![The conjunctiva closed over the replacement scleral patch graft.](cop-0008-0521-g02){#F2}
